Computational modeling toward understanding agonist binding on dopamine 3

Journal of Chemical Information and Modeling

Volumn 50, Issue 9, 2010, Pages 1633-1643

  Zhao, Yaxue ^a,c   Lu, Xuefeng ^d   Yang, Chao Yie ^e   Huang, Zhimin ^a   Fu, Wei ^f   Hou, Tingjun ^b   Zhang, Jian ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SOOCHOW UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d SECTION OF MOLECULAR BIOLOGY   (United States)

^e UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^f FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; COMPUTATIONAL CHEMISTRY; MOLECULAR DYNAMICS; NEUROPHYSIOLOGY; PHARMACODYNAMICS;

COMPUTATIONAL PROTOCOLS; EXPERIMENTAL VALUES; MOLECULAR DYNAMICS SIMULATIONS; PARKINSON'S DISEASE; PHARMACOPHORE MODELING; PHARMACOPHORE MODELS; THERAPEUTIC TARGETS; THREE DIMENSIONAL (3D) STRUCTURES;

BINDING ENERGY;

DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR DYNAMICS; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; DOPAMINE AGONISTS; HUMANS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE DATA; RECEPTORS, DOPAMINE D3; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 77957242469     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci1002119     Document Type: Article

References (65)

1. Sokoloff, P.; Giros, B.; Martres, M. P.; Bouthenet, M. L.; Schwartz, J. C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 1990, 347, 146-151 (Pubitemid 20315872)
2. Landwhermeyer, B.; Mengod, G.; Palacios, J. M. Dopamine D3 receptor mRNA and binding sites in human brain Mol. Brain Res. 1993, 18, 187-192 (Pubitemid 23100252)
3. Murray, A. M.; Ryoo, H. L.; Gurevich, E.; Joyce, J. N. Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 11271-11275 (Pubitemid 24349668)
4. Bouthenet, M. L.; Souil, E.; Martres, M. P.; Sokoloff, P.; Giros, B.; Schwartz, J. C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA Brain Res. 1991, 564, 203-219
5. Joyce, J. N.; Millan, M. J. Dopamine D3 receptor agonists for protection and repair in Parkinson's disease Curr. Opin. Pharmacol. 2007, 7, 100-105 (Pubitemid 46238043)
6. Wustrow, D. J.; Wise, L. D.; Cody, D. M.; MacKenzie, R. G.; Georgic, L. M.; Pugsley, T. A.; Heffner, T. G. Studies of the active conformation of a novel series of benzamide dopamine D2 agonists J. Med. Chem. 1994, 37, 4251-4257
7. Bettinetti, L.; Schlotter, K.; Hubner, H.; Gmeiner, P. Interactive SAR studies: rational discovery of super-potent and highly selective D3 receptor antagonists and partial agonists J. Med. Chem. 2002, 45, 4594-4597
8. Hobrath, J. V.; Wang, S. Computational elucidation of the structural basis of ligand binding to the dopamine 3 receptor through docking and homology modeling J. Med. Chem. 2006, 49, 4470-4476 (Pubitemid 44162673)
9. Palczewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H.; Fox, B. A.; Trong, I. L.; Teller, D. C.; Okada, T.; Stenkamp, R. E.; Yamamoto, M.; Miyano, M. Crystal structure of rhodopsin: a G protein-coupled receptor Science 2000, 289, 739-745 (Pubitemid 30650186)
10. Varady, J.; Wu, X.; Fang, X.; Min, J.; Hu, Z.; Levant, B.; Wang, S. Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach J. Med. Chem. 2003, 46, 4377-4392 (Pubitemid 37238742)
11. Cherezov, V.; Rosenbaum, D. M.; Hanson, M. A.; Rasmussen, S. G.; Thian, F. S.; Kobilka, T. S.; Choi, H. J.; Kuhn, P.; Weis, W. I.; Kobilka, B. K.; Stevens, R. C. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor Science 2007, 318, 1258-1265 (Pubitemid 350172884)
12. Rasmussen, S. G.; Choi, H. J.; Rosenbaum, D. M.; Kobilka, T. S.; Thian, F. S.; Edwards, P. C.; Burghammer, M.; Ratnala, V. R.; Sanishvili, R.; Fischetti, R. F.; Schertler, G. F.; Weis, W. I.; Kobilka, B. K. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor Nature 2007, 450, 383-387 (Pubitemid 350126755)
13. Oliveira, L.; Paiva, A. C. M.; Vriend, G. A common motif in G-protein-coupled seven transmembrane helix receptors J. Comput.-Aided Mol. Des. 1993, 7, 649-658
14. Hsieh, G. C.; Hollingsworth, P. R.; Martino, B.; Chang, R.; Terranova, M. A.; O'Neill, A. B.; Lynch, J. J.; Moreland, R. B.; Donnelly-Roberts, D. L.; Kolasa, T.; Mikusa, J. P.; McVey, J. M.; Marsh, K. C.; Sullivan, J. P.; Brioni, J. D. Central mechanisms regulating penile erection in conscious rats: the dopaminergic systems related to the proerectile effect of apomorphine J. Pharmacol. Exp. Ther. 2004, 308, 330-338 (Pubitemid 38090735)
15. Lenz, C.; Boeckler, F.; Hubner, H.; Gmeiner, P. Analogues of FAUC 73 revealing new insights into the structural requirements of nonaromatic dopamine D3 receptor agonists Bioorg. Med. Chem. 2004, 12, 113-117 (Pubitemid 38096223)
16. Leopoldo, M.; Berardi, F.; Colabufo, N. A.; De Giorgio, P.; Lacivita, E.; Perrone, R.; Tortorella, V. Structure-affinity relationship study on N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamides as potent and selective dopamine D(3) receptor ligands J. Med. Chem. 2002, 45, 5727-5735 (Pubitemid 35453765)
17. Bergauer, M.; Hubner, H.; Gmeiner, P. Practical ex-chiral-pool methodology for the synthesis of dopaminergic tetrahydroindoles Tetrahedron 2004, 60, 1197-1204 (Pubitemid 38068382)
18. Lenz, C.; Haubmann, C.; Hubner, H.; Boeckler, F.; Gmeiner, P. Fancy bioisosteres: synthesis and dopaminergic properties of the endiyne FAUC 88 as a novel non-aromatic D3 agonist Bioorg. Med. Chem. 2005, 13, 185-191 (Pubitemid 39575703)
19. Pugsley, T. A.; Davis, M. D.; Akunne, H. C.; MacKenzie, R. G.; Shih, Y. H.; Damsma, G.; Wikstrom, H.; Whetzel, S. Z.; Georgic, L. M.; Cooke, L. W. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907 J. Pharmacol. Exp. Ther. 1995, 275, 1355-1366 (Pubitemid 26130641)
20. Ennis, M. D.; Stjernlöf, P.; Hoffman, R. L.; Ghazal, N. B.; Smith, M. W.; Svensson, K.; Wikström, H.; Haadsma-Svensson, S. R.; Lin, C. H. Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e] indole ring system: 2. Effects of 8-aminonitrogen substitution on serotonin receptor binding and pharmacology J. Med. Chem. 1995, 38, 2217-2230
21. Millan, M. J.; Peglion, J. L.; Vian, J.; Rivet, J. M.; Brocco, M.; Gobert, A.; Newman-Tancredi, A.; Dacquet, C.; Bervoets, K.; Girardon, S. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy J. Pharmacol. Exp. Ther. 1995, 275, 885-898 (Pubitemid 26027050)
22. Chen, J.; Collins, G. T.; Zhang, J.; Yang, C. Y.; Levant, B.; Woods, J.; Wang, S. Design, Synthesis and Evaluation of a Potent and Selective Ligand for the Dopamine 3 (D3) Receptor with a Novel In vivo Behavioral Profile J. Med. Chem. 2008, 51, 5905-5908
23. Damsma, G.; Bottema, T.; Westerink, B. H.; Tepper, P. G.; Dijkstra, D.; Pugsley, T. A.; MacKenzie, R. G.; Heffner, T. G.; Wikström, H. Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand Eur. J. Pharmacol. 1993, 249, R9-R10 (Pubitemid 2011936)
24. Fears, R. B. Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease. WO 9323035, 19931125, 1993.
25. Stemp, G.; Ashmeade, T.; Branch, C. L.; Hadley, M. S.; Hunter, A. J.; Johnson, C. N.; Nash, D. J.; Thewlis, K. M.; Vong, A. K.; Austin, N. E.; Jeffrey, P.; Avenell, K. Y.; Boyfield, I.; Hagan, J. J.; Middlemiss, D. N.; Reavill, C.; Riley, G. J.; Routledge, C.; Wood, M. Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4- quinolinecarboxamide (SB-277011): a potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat J. Med. Chem. 2000, 43, 1878-1885 (Pubitemid 30305020)
26. Discovery Studio, Accelrys, Inc. San Diego, CA, 2005.
27. Smellie, A.; Teig, S. L.; Towbin, P. Poling: Promoting conformational variation J. Comput. Chem. 1995, 16, 171-187
28. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations J. Comput. Chem. 1983, 4, 187-217
29. Steindl, T.; Langer, T. Influenza virus neuraminidase inhibitors: generation and comparison of structure-based and common feature pharmacophore hypotheses and their application in virtual screening J. Chem. Inf. Comput. Sci. 2004, 44, 1849-1856
30. Sali, A.; Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints J. Mol. Biol. 1993, 234, 779-815 (Pubitemid 24007801)
31. Javitch, J. A.; Fu, D.; Chen, J.; Karlin, A. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method Neuron 1995, 14, 825-831 (Pubitemid 26006489)
32. Jones, G.; Willett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking J. Mol. Biol. 1997, 267, 727-748 (Pubitemid 27170693)
33. Wang, R.; Lai, L.; Wang, S. Futher development and validation of empirical scoring functions for structure-based binding affinity prediction J. Comput.-Aided Mol. Des. 2002, 16, 11-26 (Pubitemid 34855041)
34. Cheng, T.; Li, X.; Li, Y.; Liu, Z.; Wang, R. Comparative assessment of scoring functions on a diverse test set J. Chem. Inf. Model. 2009, 49, 1079-1093
35. Berendsen, H. J. C.; Spoel, V. D.; Drunen, R. V. GROMACS: a message-passing parallel molecular dynamics implementation Comput. Phys. Commun. 1995, 95, 43-56
36. Van Aalten, D. M. F.; Bywater, R.; Findlay, J. B. C.; Hendlich, M.; Hooft, R. W. W.; Vriend, G. PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules J. Comput.-Aided Mol. Des. 1996, 10, 255-262
37. Breneman, C. M.; Wiberg, K. B. Determining atom-centered monopoles from molecular electrostatic potentials J. Comput. Chem. 1990, 11, 361-397
38. Frisch, M.; J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A., Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, N. J.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 98, revision A.7; Gaussian, Inc.: Pittsburgh, PA., 1998.
39. Efremov, R. G.; Nolde, D. E.; Vergoten, G.; Arseniev, A. S. A solvent model for simulations of peptides in bilayers. II. Membrane-spanning R-helices Biophys. J. 1999, 76, 2460-2471 (Pubitemid 29264608)
40. Heller, H.; Schaefer, M.; Schulten, K. Molecular dynamics simulation of a bilayer of 200 lipids in the gel and in the liquid-crystal phases J. Phys. Chem. 1993, 97, 8343-8360
41. Berendsen, H. J. C.; Postma, J. P. M.; Gunsteren, W. F.; Dinola, A.; Haak, J. R. Molecular dynamics with coupling to an external bath J. Chem. Phys. 1984, 81, 3684-3690
42. Hess, B.; Bekker, H.; Berendsen, H. J. C.; Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations J. Comput. Chem. 1997, 18, 1463-1472 (Pubitemid 127637344)
43. Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald: an N•log(N) method for Ewald sums in large systems J. Chem. Phys. 1997, 98, 10089-10092
44. Boeckler, F.; Gmeiner, P. Dopamine D3 receptor ligands: recent advances in the control of subtype selectivity and intrinsic activity Biochim. Biophys. Acta 2007, 1768, 871-887 (Pubitemid 46452549)
45. Boeckler, F.; Gmeiner, P. The structural evolution of dopamine D3 receptor ligands: structure-activity relationships and selected neuropharmacological aspects Pharmacol. Ther. 2006, 112, 281-333 (Pubitemid 44301495)
46. Hübner, H.; Haubmann, C.; Utz, W.; Gmeiner, P. Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D(3) subtype J. Med. Chem. 2000, 43, 756-762 (Pubitemid 30127169)
47. van Leeuwen, D. H.; Eisenstein, J.; O'Malley, K.; MacKenzie, R. G. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells Mol. Pharmacol. 1995, 48, 344-351
48. Filteau, F.; Veilleux, F.; Levesque, D. Effects of reciprocal chimeras between the C-terminal portion of third intracellular loops of the human dopamine D2 and D3 receptors FEBS Lett. 1999, 447, 251-256 (Pubitemid 29146096)
49. Shi, L.; Simpson, M. M.; Ballesteros, J. A.; Javitch, J. A. The first transmembrane segment of the dopamine D2 receptor: Accessibility in the binding site crevice and position in the transmembrane bundle Biochemistry 2001, 40, 12339-12348 (Pubitemid 32959756)
50. Javitch, J. A.; Fu, D.; Chen, J. Residues in the fifth membranespanning segment of the dopamine D2 receptor exposed in the binding-site crevice Biochemistry 1995, 34, 16433-16439 (Pubitemid 26006489)
51. Javitch, J. A.; Fu, D.; Chen, J. Differentiating dopamine D2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice Mol. Pharmacol. 1996, 49, 692-698 (Pubitemid 26117154)
52. Javitch, J. A.; Ballesteros, J. A.; Weinstein, H.; Chen, J. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice Biochemistry 1998, 37, 998-1006 (Pubitemid 28100601)
53. Javitch, J. A.; Ballesteros, J. A.; Chen, J.; Chiappa, V.; Simpson, M. M. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment Biochemistry 1999, 38, 7961-7968 (Pubitemid 129516647)
54. Javitch, J. A.; Shi, L.; Simpson, M. M.; Chen, J.; Chiappa, V.; Visiers, I.; Weinstein, H.; Ballesteros, J. A. The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle Biochemistry 2000, 39, 12190-12199 (Pubitemid 32959756)
55. Fu, D.; Ballesteros, J. A.; Weinstein, H.; Chen, J.; Javitch, J. A. Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice Biochemistry 1996, 35, 11278-11285 (Pubitemid 26299300)
56. Alberts, G. L.; Pregenzer, J. F.; Im, W. B. Br. Contributions of cysteine 114 of the human D3 dopamine receptor to ligand binding and sensitivity to external oxidizing agents J. Pharmacol. 1998, 125, 705-710
57. Sartania, N.; Strange, P. G. Role of conserved serine residues in the interaction of agonists with D3 dopamine receptors J. Neurochem. 1999, 72, 2621-2624 (Pubitemid 29242216)
58. Lundstrom, K.; Turpin, M. P.; Large, C.; Robertson, G.; Thomas, P.; Lewell, X. Q. Mapping of dopamine D3 receptor binding site by pharmacological characterization of mutants expressed in CHO cells with the Semliki Forest virus system J. Recept. Signal Transduction Res. 1998, 18, 133-150 (Pubitemid 28299116)
59. Mansour, A.; Meng, F.; Meador-Woodruff, J. H.; Taylor, L. P.; Civelli, O.; Akil, H. Site-directed mutagenesis of the human dopamine D2 receptor Eur. J. Pharmacol. 1992, 227, 205-214
60. Cho, W.; Taylor, L. P.; Mansour, A.; Akil, H. Hydrophobic residues of the D2 dopamine receptor are important for binding and signal transduction J. Neurochem. 1995, 65, 2105-2115
61. Daniell, S. J.; Strange, P. G.; Naylor, L. H. Site-directed mutagenesis of Tyr417 in the rat D2 dopamine receptor Biochem. Soc. Trans. 1994, 22, 144S (Pubitemid 24166065)
62. Ballesteros, J. A.; Jensen, A. D.; Liapakis, G.; Rasmussen, S. G. F.; Shi, L.; Gether, U.; Jonathan, J. A. Activation of the b2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6 J. Biol. Chem. 2001, 276, 29171-29177 (Pubitemid 37452006)
63. Fu, W.; Shen, J.; Luo, X.; Zhu, W.; Cheng, J.; Yu, K.; Briggs, J. M.; Jin, G.; Chen, K.; Jiang, H. Dopamine D1 receptor agonist and D2 receptor antagonist effects of the natural product (-)-stepholidine: molecular modeling and dynamics simulations Biophys. J. 2007, 93, 1431-1441 (Pubitemid 47403289)
64. González-Maeso, J.; Sealfon, S. C. Agonist-trafficking and hallucinogens Curr. Med. Chem. 2009, 16, 1017-1027
65. Iwasiow, R. M.; Nantel, M. F.; Tiberi, M. Delineation of the structural basis for the activation properties of the dopamine D1 receptor subtypes J. Biol. Chem. 1999, 274, 31882-31890 (Pubitemid 129503775)